WebMar 27, 2024 · Analyst Forecast. According to 7 analysts, the average rating for DFFN stock is "Buy." The 12-month stock price forecast is $40.8, which is an increase of 691.00% from the latest price. WebApr 18, 2024 · Diffusion Pharmaceuticals ( NASDAQ: DFFN) is trading sharply lower in the morning hours on Monday after the development stage biotech announced a 1-for-50 reverse stock split of its common stock ...
Diffusion Pharmaceuticals Sees Significant Progress in its Strategic ...
WebDFFN Stock Price - Diffusion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing novel therapies that enhance the body's ability to deliver oxygen. … WebMay 14, 2024 · By David Bautz, PhD NASDAQ:DFFN READ THE FULL DFFN RESEARCH REPORT Business Update Encouraging Trends in COVID-19 Trial On May 10, 2024, Diffusion Pharmaceuticals, Inc. (NASDAQ:DFFN) announced the ... ciehf uk
StockNews.com Initiates Coverage on Diffusion Pharmaceuticals (NASDAQ:DFFN)
WebFind the latest Diffusion Pharmaceuticals Inc. (DFFN) stock quote, history, news and other vital information to help you with your stock trading and investing. WebMay 5, 2024 · Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or “the Company”), a cutting-edge biotechnology company developing new treatments for life-threatening medical conditions by improving the body’s ability to deliver oxygen to the areas where it is needed most, today announced that the U.S. Food and Drug Administration … WebGet Diffusion Pharmaceuticals Inc (DFFN:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. dhanhind app